4 ms·
So, continuing on the meta track, there are several cases when the private sector fails, which I'll try to categorize: 1. Government intervention screwing up w
by harshreality 13y ago
So, continuing on the meta track, there are several cases when the private sector fails, which I'll try to categorize:
1. Government intervention screwing up what would work in a purely free market.
2. Markets that free enterprise is not equipped to handle. Massive front-end costs combined with unpredictable or insufficient future revenue (for instance, reducing or eliminating externalities in a way that the company can't capitalize on renders something unworkable for the free market).
3. Markets that have a pathological condition where they are inelastic and when there are less-desirable substitute goods one of which is vastly more profitable.
4. Markets that are monopolies or oligopolies: where there is insufficient competition.
Is it even productive to engage in a discussion focusing on category 1, when pharma has issues in all four categories, and reducing government regulation in any way even if it's merely to reduce unnecessary up-front drug development costs (which I agree is a noble goal) is likely to make some of those other pathologies worse?
edit to reduce clutter: fair enough.
- hga 13y agoObviously we have grave disagreements here, enough in my opinion that I don't think it's productive for me to reply further. But I'd add at least a "5": too many monopsonies (http://en.wikipedia.org/wiki/Monopsony http://en.wikipedia.org/wiki/Monopsony), e.g. nation states negotiating directly with drug companies, and insisting on prices barely above the costs of goods (well, I'm sure insisting on less, but settling on that).